Histone deacefylase inhibitor valproic acid promotes the induction of pluripotency in mouse fibroblasts by suppressing reprogramming-induced senescence stress
Histone deacefylase inhibitor valproic acid promotes the induction of pluripotency in mouse fibroblasts by suppressing reprogramming-induced senescence stress
复制标题
组蛋白去乙酰化酶抑制剂丙戊酸通过抑制重编程诱导的衰老应激促进小鼠成纤维细胞多能性的诱导
DOI:
10.1016/j.yexcr.2015.06.003
复制
发表时间:
2015
影响因子:
3.7
通讯作者:
Li Wei
中科院分区:
文献类型:
--
作者:
Zhai Yingying;Chen Xi;Yu Dehai;Li Tao;Cui Jiuwei;Wang Guanjun;Hu Ji-Fan;Li Wei
Histone deacetylase inhibitor valproic acid (VPA) has been used to increase the reprogramming efficiency of induced pluripotent stem cell (iPSC) from somatic cells, yet the specific molecular mechanisms underlying this effect is unknown. Here, we demonstrate that reprogramming with lentiviruses carrying the iPSC-inducing factors (Oct4-Sox2-Klf4-cMyc, OSKM) caused senescence in mouse fibroblasts, establishing a stress barrier for cell reprogramming. Administration of VPA protected cells from reprogramming-induced senescent stress. Using anin vitropre-mature senescence model, we found that VPA treatment increased cell proliferation and inhibited apoptosis through the suppression of the p16/p21 pathway. In addition, VPA also inhibited the G2/M phase blockage derived from the senescence stress. These findings highlight the role of VPA in breaking the cell senescence barrier required for the induction of pluripotency.